BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santiago-Sánchez GS, Pita-Grisanti V, Quiñones-Díaz B, Gumpper K, Cruz-Monserrate Z, Vivas-Mejía PE. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer. Int J Mol Sci 2020;21:E4365. [PMID: 32575507 DOI: 10.3390/ijms21124365] [Cited by in Crossref: 12] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Celepli P, Bigat İ, Karabulut S, Celepli S, Hücümenoğlu S. Evaluation of Lipocalin-2 and Twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition. Annals of Diagnostic Pathology 2022;59:151973. [DOI: 10.1016/j.anndiagpath.2022.151973] [Reference Citation Analysis]
2 Tian R, Li F, Che S, Song M, Liu L, Guo R, Li Z, Hu X, Zhang H, Hussein AF. Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/8030243] [Reference Citation Analysis]
3 Hao P, Zhang J, Fang S, Jia M, Xian X, Yan S, Wang Y, Ren Q, Yue F, Cui H. Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway. Human Cell. [DOI: 10.1007/s13577-022-00735-z] [Reference Citation Analysis]
4 Pita-grisanti V, Chasser K, Sobol T, Cruz-monserrate Z. Understanding the Potential and Risk of Bacterial Siderophores in Cancer. Front Oncol 2022;12:867271. [DOI: 10.3389/fonc.2022.867271] [Reference Citation Analysis]
5 Zhang H, Wu P, Guo C, Zhang C, Zhao Y, Tan D, An J, Shi C. Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine. Biochem Biophys Rep 2022;31:101291. [PMID: 35669987 DOI: 10.1016/j.bbrep.2022.101291] [Reference Citation Analysis]
6 Gupta U, Ghosh S, Wallace CT, Shang P, Xin Y, Nair AP, Yazdankhah M, Strizhakova A, Ross MA, Liu H, Hose S, Stepicheva NA, Chowdhury O, Nemani M, Maddipatla V, Grebe R, Das M, Lathrop KL, Sahel JA, Zigler JS Jr, Qian J, Ghosh A, Sergeev Y, Handa JT, St Croix CM, Sinha D. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy 2022;:1-20. [PMID: 35473441 DOI: 10.1080/15548627.2022.2062887] [Reference Citation Analysis]
7 Li X, Ma J, Leng L, Han M, Li M, He F, Zhu Y. MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis. Front Genet 2022;13:806842. [PMID: 35186034 DOI: 10.3389/fgene.2022.806842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zisman D, Safieh M, Simanovich E, Feld J, Kinarty A, Zisman L, Gazitt T, Haddad A, Elias M, Rosner I, Kaly L, Rahat MA. Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147. Front Immunol 2021;12:739592. [PMID: 34975837 DOI: 10.3389/fimmu.2021.739592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kou F, Cheng Y, Shi L, Liu J, Liu Y, Shi R, Peng G, Li J. LCN2 as a Potential Diagnostic Biomarker for Ulcerative Colitis-Associated Carcinogenesis Related to Disease Duration. Front Oncol 2021;11:793760. [PMID: 35111677 DOI: 10.3389/fonc.2021.793760] [Reference Citation Analysis]
10 García-Hernández L, García-Ortega MB, Ruiz-Alcalá G, Carrillo E, Marchal JA, García MÁ. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. Int J Mol Sci 2021;23:370. [PMID: 35008796 DOI: 10.3390/ijms23010370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Crescenzi E, Leonardi A, Pacifico F. NGAL as a Potential Target in Tumor Microenvironment. Int J Mol Sci 2021;22:12333. [PMID: 34830212 DOI: 10.3390/ijms222212333] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Zhu S, Ma AH, Zhu Z, Adib E, Rao T, Li N, Ni K, Chittepu VCSR, Prabhala R, Garisto Risco J, Kwiatkowski D, Mouw K, Sonpavde G, Cheng F, Pan CX. Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer. J Immunother Cancer 2021;9:e002917. [PMID: 34725212 DOI: 10.1136/jitc-2021-002917] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Hwang S, Yun H, Moon S, Cho YE, Gao B. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:751802. [PMID: 34707573 DOI: 10.3389/fendo.2021.751802] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Wegner MS, Schömel N, Olzomer EM, Trautmann S, Olesch C, Byrne FL, Brüne B, Gurke R, Ferreirós N, Weigert A, Geisslinger G, Hoehn KL. Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells. Cell Mol Life Sci 2021;78:7025-41. [PMID: 34626204 DOI: 10.1007/s00018-021-03958-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Wang F, Zhang C, Cheng H, Liu C, Lu Z, Zheng S, Wang S, Sun N, He J. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2. Cell Death Dis 2021;12:901. [PMID: 34601488 DOI: 10.1038/s41419-021-04155-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Santiago-Sánchez GS, Noriega-Rivera R, Hernández-O'Farrill E, Valiyeva F, Quiñones-Diaz B, Villodre ES, Debeb BG, Rosado-Albacarys A, Vivas-Mejía PE. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. Int J Mol Sci 2021;22:8581. [PMID: 34445288 DOI: 10.3390/ijms22168581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, Vivas-Mejía P, Woodward WA, Debeb BG. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol 2021. [PMID: 34342930 DOI: 10.1002/1878-0261.13074] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Bahrun U, Wildana W, Rahmawati H, Kurniawan LB, Hamdani W. Lipocalin 2 could predict circulating MMP9 levels in patients with breast cancer. Breast Dis 2021;40:S115-7. [PMID: 34057126 DOI: 10.3233/BD-219017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Sanegre S, Eritja N, de Andrea C, Diaz-Martin J, Diaz-Lagares Á, Jácome MA, Salguero-Aranda C, García Ros D, Davidson B, Lopez R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. Front Cell Dev Biol 2021;9:670185. [PMID: 34150764 DOI: 10.3389/fcell.2021.670185] [Reference Citation Analysis]
20 Roemhild K, von Maltzahn F, Weiskirchen R, Knüchel R, von Stillfried S, Lammers T. Iron metabolism: pathophysiology and pharmacology. Trends Pharmacol Sci 2021;42:640-56. [PMID: 34090703 DOI: 10.1016/j.tips.2021.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hsieh YH, Tsai JP, Yu CL, Lee CC, Hsu JC, Chen JC. Overexpression of Lipocalin-2 Inhibits Proliferation and Invasiveness of Human Glioblastoma Multiforme Cells by Activating ERK Targeting Cathepsin D Expression. Biology (Basel) 2021;10:390. [PMID: 34062746 DOI: 10.3390/biology10050390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Salnikow K. Role of iron in cancer. Semin Cancer Biol 2021:S1044-579X(21)00102-4. [PMID: 33901632 DOI: 10.1016/j.semcancer.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Li N, Chen J, Wang P, Fan H, Hou S, Gong Y. Major signaling pathways and key mediators of macrophages in acute kidney injury (Review). Mol Med Rep 2021;23:455. [PMID: 33880578 DOI: 10.3892/mmr.2021.12094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Krizanac M, Mass Sanchez PB, Weiskirchen R, Asimakopoulos A. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2021;22:2865. [PMID: 33799862 DOI: 10.3390/ijms22062865] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
25 Yao B, Giel M, Hong Y. Detection of kidney disease biomarkers based on fluorescence technology. Mater Chem Front 2021;5:2124-42. [DOI: 10.1039/d0qm01009j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
26 Roche O, Fernández-Aroca DM, Arconada-Luque E, García-Flores N, Mellor LF, Ruiz-Hidalgo MJ, Sánchez-Prieto R. p38β and Cancer: The Beginning of the Road. Int J Mol Sci 2020;21:E7524. [PMID: 33053909 DOI: 10.3390/ijms21207524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]